Thomas Pharmaceuticals Files Registration Statement with SEC in Anticipation of Spin Off by iVoice, Inc. to its Shareholders

MATAWAN, N.J.--(BUSINESS WIRE)--iVoice, Inc. (OTC Bulletin Board: IVOI), today announced that its wholly owned subsidiary, Thomas Pharmaceuticals, Ltd. (“Thomas Pharmaceuticals”) has filed with the Securities and Exchange Commission a Registration Statement on Form SB-2 in anticipation of the spin-off of Thomas Pharmaceuticals by iVoice to the shareholders of iVoice.